jinghua pharmaceutical group (002349.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
According to the Zhitong Finance APP, jinghua pharmaceutical group (002349.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue of 1.045 billion yuan, a decrease of 6.65% year-on-year. The net income attributable to shareholders of the listed company was 0.164 billion yuan, a decrease of 15.93% year-on-year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.156 billion yuan, a decrease of 17.42% year-on-year.